Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity
Christoph Kopp(Friedrich-Alexander-Universität Erlangen-Nürnberg), Erich Minar(Medical University of Vienna), Rupert Ecker(Vienna University of Economics and Business), Sabine Steiner(Helmholtz Munich), Manfred Cejna(Landeskrankenhaus Feldkirch), Gerald Maurer(European Society of Radiology), Thomas Hölzenbein(Vienna General Hospital), Johann Wojta(Medical University of Vienna), Helga Bergmeister(Medical University of Vienna), Rodrig Marculescu(Medical University of Vienna), Isabella Mosberger(Vienna Biocenter), Rainer de Martin(Deaconess Hospital), Bernd R. Binder(Infineon Technologies (Germany)), Christoph Kaun(University of Vienna), Reinhard Horvat(Medical University of Vienna), Johannes M. Breuss(Medical University of Vienna), Daniela Seidinger(Wilhelminen Hospital)
Cited by 49
Related Papers
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Endoluminal Stent–Grafts for Infrarenal Abdominal Aortic Aneurysms
|New England Journal of Medicine|1997|678